High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer
β Scribed by Edward P. Ambinder; Marjorie Perloff; Takao Ohnuma; Hugh F. Biller; James F. Holland
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 506 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
High dose methotrexate followed by citrovorum factor reversal has been utilized in twenty-six patients with advanced cancer. Four of 10 patients with head and neck cancer had an objective response. One of 7 patients with metastatic osteosarcoma to the lungs had stabilization with twenty treatments over 23 months. One patient with acute lymphocytic leukemia developed marrow aplasia but did not attain remission. The regimen was well tolerated when meticulous attention was paid to hydration, urine alkalinization, renal function and third space fluid accumulation. Life-threatening or lethal toxicity was encountered when these phenomena were not scrupulously observed.
π SIMILAR VOLUMES
The incidence of malignant mesothelioma has increased greatly in the last 40 years. Current and recent past exposure to asbestos is expected to substantially increase this incidence. We report nine cases of malignant mesothelioma which temporarily responded to treatment with high-dose methotrexate-c
## Abstract Thirty patients with advanced measurable colorectal cancer were randomized to receive either methotrexate (MTX) 200 mg/m^2^ or 40 mg/m^2^, followed in four hours by 5βfluorouracil (5βFU) 600 mg/m^2^. Patients receiving the higher dose MTX were given leucovorin rescue 24 hours later. Eig
## Background: Multiple lymphomatous polyposis (mlp) results from gastrointestinal involvement by a b-cell lymphoma that originates from the mantle zone of lymphoid follicles. this well described clinicopathologic entity has a poor prognosis: the rate of complete response after conventional chemoth